| R 246 |
| 2024 -- S 3017 Enacted 05/02/2024 |
| S E N A T E R E S O L U T I O N |
| PROCLAIMING MAY 5TH THROUGH MAY 11TH OF 2024, TO BE "TARDIVE DYSKINESIA (TD) AWARENESS WEEK" IN THE STATE OF RHODE ISLAND |
Introduced By: Senators Miller, Picard, Felag, Zurier, Bissaillon, Britto, Rogers, DeLuca, Burke, and F. Lombardi |
| Date Introduced: May 02, 2024 |
| WHEREAS, Many people living with serious mental illnesses (for example, bipolar |
| disorder, major depressive disorder, schizophrenia and schizoaffective disorder) or |
| gastrointestinal disorders (for example, gastroparesis, upset stomach, nausea and vomiting) may |
| be treated with medications that work as dopamine receptor blocking agents, including |
| antipsychotics and antiemetics; and |
| WHEREAS, While ongoing treatment with these medications can be necessary, |
| prolonged use is associated with tardive dyskinesia (TD), an involuntary movement disorder that |
| is characterized by uncontrollable, abnormal and repetitive movements of the face, torso, limbs, |
| and fingers or toes; and |
| WHEREAS, Even mild symptoms of TD can impact people physically, socially and |
| emotionally; and |
| WHEREAS, It is estimated that TD affects approximately 600,000 people in the United |
| States, and approximately 65 percent of people with TD have not been diagnosed, making it |
| important to raise awareness about the symptoms; and |
| WHEREAS, It is important that people taking these medications be monitored for TD by |
| a healthcare provider. Regular screening for TD is recommended by the American Psychiatric |
| Association; and |
| WHEREAS, Clinical research has led to approval of treatments for adults with TD by the |
| U.S. Food and Drug Administration, and recognition and treatment of TD can make a positive |
| impact in the lives of many people experiencing psychotic and mood disorders; and |
| WHEREAS, The State of Rhode Island needs to do all it can to raise awareness of TD |
| among the public and medical community; now, therefore be it |
| RESOLVED, That this Senate of the State of Rhode Island hereby proclaims May 5th |
| through May 11th of 2024, to be "Tardive Dyskinesia (TD) Awareness Week" in the State of |
| Rhode Island; and be it further |
| RESOLVED, That this Senate hereby encourages anyone experiencing uncontrollable, |
| abnormal and repetitive movements to consult their healthcare provider regarding their |
| symptoms; and be it further |
| RESOLVED, That the Secretary of State be and hereby is authorized and directed to |
| transmit a duly certified copy of this resolution to Ms. Karla Kiriako, Director, State Government |
| Affairs-East, Neurocrine, Inc. |
| ======== |
| LC005695 |
| ======== |